To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene RNASEH1TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
221 supporting clones for gene RNASEH1 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BI553044 brain, hippocampus .a 1 to 606 1 to 612   tiling clone,   612/760
(80 %)
18 diff
(97.7 %id)
TI_44170534   .a 6 to 606 148 to 754       607/902
(67 %)
18 diff
(98.1 %id)
DA532761 brain .a 252 to 739 2 to 489   capped   488/488
(100 %)
0 diff
(100 %id)
DA007067   .a 254 to 820 2 to 568   capped   567/567
(100 %)
1 diff
(99.9 %id)
DA881431   .a 256 to 806 2 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
DB239152 trachea .a 264 to 857 2 to 595   capped   594/594
(100 %)
0 diff
(100 %id)
CR594242 Placenta Cot 25-normalized .a 265 to 1892 1 to 1628 exact tiling clone,   1628/1628
(100 %)
0 diff
(100 %id)
BQ921568 leiomyosarcoma, uterus .a 269 to 1135 4 to 876       873/935
(93 %)
25 diff
(97.4 %id)
BP347071 brain .a 270 to 856 1 to 587       587/587
(100 %)
1 diff
(99.9 %id)
BX475460   .a 271 to 688 1 to 426       426/426
(100 %)
10 diff
(97.7 %id)
NM_002936.3   .a 272 to 1904 1 to 1633 exact RefSeq, AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 1633/1633
(100 %)
0 diff
(100 %id)
CR596638 B cells (Ramos cell line) Cot 25-normalized .a 273 to 1852 1 to 1580 exact     1580/1580
(100 %)
0 diff
(100 %id)
AL560874 B cells from Burkitt lymphoma .a 273 to 1041 1 to 767   fully sequenced,   767/767
(100 %)
5 diff
(99.4 %id)
BG824728 adenocarcinoma cell line, colon .a 275 to 960 1 to 686       686/686
(100 %)
1 diff
(99.9 %id)
BU598448 mixed (pool of 40 RNAs) .a 275 to 856 1 to 597       597/902
(66 %)
21 diff
(97.7 %id)
BU929741 placenta .a 276 to 1011 1 to 739       739/782
(94 %)
13 diff
(98.4 %id)
AL554334 placenta, Placenta Cot 25-normalized .a 277 to 1161 10 to 894   fully sequenced,   885/894
(98 %)
6 diff
(99.4 %id)
AF039652   .a 281 to 1422 1 to 1142 exact AAA   1142/1142
(100 %)
2 diff
(99.9 %id)
DA005806   .a 284 to 599 2 to 317   capped   316/316
(100 %)
0 diff
(100 %id)
DA001940   .a 285 to 782 2 to 499   capped   498/498
(100 %)
0 diff
(100 %id)
CN265744 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 285 to 400 1 to 116       116/116
(100 %)
0 diff
(100 %id)
BG420594 Kidney, renal cell adenocarcinoma .a 286 to 1013 1 to 726       726/864
(84 %)
7 diff
(99.2 %id)
BG778946 adenocarcinoma, Prostate .a 286 to 1007 1 to 718       718/718
(100 %)
18 diff
(97.5 %id)
BG719686 testis .a 286 to 905 1 to 619       619/619
(100 %)
2 diff
(99.7 %id)
CB961021 Human Placenta, placenta .a 289 to 1009 27 to 752       726/772
(94 %)
13 diff
(98.4 %id)
BP289593 lung .a 289 to 869 1 to 581       581/581
(100 %)
3 diff
(99.5 %id)
BP377249 uterus .a 289 to 868 1 to 579       579/579
(100 %)
5 diff
(99.2 %id)
DA062040 cerebellum .a 290 to 847 2 to 559   capped   558/558
(100 %)
1 diff
(99.9 %id)
DB294347   .a 290 to 1069 2 to 783   capped   782/785
(99 %)
4 diff
(99.5 %id)
BG707168 brain, hypothalamus .a 291 to 868 1 to 577       577/577
(100 %)
6 diff
(99.0 %id)
BP192825 brain .a 292 to 874 1 to 583       583/583
(100 %)
0 diff
(100 %id)
BC002973 Lung, small cell carcinoma .a 292 to 1431 1 to 1140 exact available from MGC, AAA   1140/1140
(100 %)
0 diff
(100 %id)
BP258763 heart .a 292 to 844 1 to 553       553/553
(100 %)
0 diff
(100 %id)
BI862715 breast, mammary adenocarcinoma, cell line .a 292 to 973 1 to 689       689/689
(100 %)
19 diff
(97.3 %id)
TI_57192080   .a 292 to 973 54 to 742       689/689
(100 %)
19 diff
(97.3 %id)
AU099791   .a 292 to 566 26 to 300       275/300
(91 %)
6 diff
(98.0 %id)
DA583876 lung .a 293 to 876 2 to 585   capped   584/586
(99 %)
5 diff
(99.2 %id)
BG767598 melanotic melanoma, high MDR (cell line), skin .a 293 to 1055 1 to 764       764/764
(100 %)
11 diff
(98.6 %id)
DA909974   .a 293 to 858 2 to 567   capped   566/572
(98 %)
1 diff
(99.9 %id)
DB251063 uterus .a 293 to 749 2 to 458   capped   457/457
(100 %)
0 diff
(100 %id)
BP280920   .a 295 to 876 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BP213238 cerebrum .a 296 to 884 1 to 588       588/588
(100 %)
1 diff
(99.9 %id)
DA571427 whole embryo, mainly head .a 296 to 1066 2 to 774   capped   773/773
(100 %)
7 diff
(99.1 %id)
BF689462 melanotic melanoma, high MDR (cell line), skin .a 296 to 901 1 to 606   fully sequenced,   606/606
(100 %)
1 diff
(99.9 %id)
BU595053 mixed (pool of 40 RNAs) .a 296 to 1103 1 to 813       813/818
(99 %)
14 diff
(98.3 %id)
CR747871 astrocytoma grade IV, cell line, brain .a 298 to 794 34 to 531       498/531
(93 %)
7 diff
(98.7 %id)
BM451915 eye, retinoblastoma .a 298 to 1013 11 to 727       717/916
(78 %)
9 diff
(99.1 %id)
TI_57243008   .a 298 to 806 27 to 555       527/932
(56 %)
24 diff
(97.5 %id)
DN992388 brain, whole brain .a 300 to 1013 1 to 714       714/719
(99 %)
6 diff
(99.2 %id)
CV799709 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 301 to 1013 1 to 710       710/783
(90 %)
9 diff
(98.9 %id)
AK075490 ovary, tumor tissue .a 302 to 1904 1 to 1604 exact     1604/1604
(100 %)
3 diff
(99.9 %id)
BP225672   .a 302 to 883 1 to 581       581/581
(100 %)
1 diff
(99.9 %id)
DA812729 ovary, tumor tissue .a 303 to 1093 2 to 795   capped   794/795
(99 %)
13 diff
(98.4 %id)
BX416456 neuroblastoma .a 304 to 1367 1 to 1050 S96A K97S R98D L99S R100V ...     1050/1068
(98 %)
29 diff
(97.3 %id)
BI916440 brain .a 304 to 806 1 to 523       520/900
(57 %)
39 diff
(95.7 %id)
BM810651 astrocytoma grade IV, cell line, brain .a 304 to 1280 1 to 977 N228M W230G K231R T232Q S233V ...     977/1060
(92 %)
14 diff
(98.7 %id)
TI_44459718   .a 305 to 960 62 to 717       656/717
(91 %)
6 diff
(99.2 %id)
CX165913 human embryonic stem cells differentiated toan early endodermal cell type .a 307 to 1037 1 to 731       731/731
(100 %)
1 diff
(99.9 %id)
CX165840 human embryonic stem cells differentiated toan early endodermal cell type .a 307 to 1068 1 to 761       761/761
(100 %)
1 diff
(99.9 %id)
AA312554   .a 309 to 822 1 to 516       516/516
(100 %)
4 diff
(99.3 %id)
AF048995   .a 309 to 1430 9 to 1130 L4F AAA   1122/1130
(99 %)
7 diff
(99.4 %id)
CN268994 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 309 to 988 1 to 680       680/680
(100 %)
2 diff
(99.8 %id)
BI518784 leukocyte .a 309 to 960 1 to 652       652/652
(100 %)
0 diff
(100 %id)
BE265817 lung, small cell carcinoma .a 311 to 771 1 to 461       461/471
(97 %)
1 diff
(99.8 %id)
BF129039 B-cells, primary B-cells from tonsils (cell line) .a 311 to 1017 1 to 703       703/704
(99 %)
9 diff
(98.8 %id)
DB450018 testis .a 312 to 666 1 to 356       356/356
(100 %)
21 diff
(94.2 %id)
BQ942688 large cell carcinoma, lung .a 313 to 926 1 to 614       614/868
(70 %)
4 diff
(99.6 %id)
BE786259 large cell carcinoma, lung .a 315 to 1042 1 to 717       717/937
(76 %)
18 diff
(98.1 %id)
DA688636   .a 317 to 861 2 to 546   capped   545/545
(100 %)
2 diff
(99.7 %id)
BM541420 leiomyosarcoma, uterus .a 323 to 1356 6 to 1051 K227X N228K G229W W230V K231E ...     1046/1054
(99 %)
40 diff
(96.3 %id)
CA775004 Pancreas, Purified pancreatic islet .a 323 to 1087 1 to 765       765/765
(100 %)
1 diff
(99.9 %id)
BM805842 brain, hippocampus .a 324 to 1096 20 to 805       786/1198
(65 %)
25 diff
(98.0 %id)
BX394121 Neuroblastoma Cot 25-normalized .a 326 to 1389 1 to 1056 A95V S96A K97S R98D L99S ...     1056/1062
(99 %)
22 diff
(98.0 %id)
DA656571   .a 330 to 905 2 to 577   capped   576/576
(100 %)
1 diff
(99.9 %id)
BP332146 renal proximal tubule .a 332 to 915 1 to 584       584/584
(100 %)
3 diff
(99.5 %id)
DB095644 testis .a 332 to 890 2 to 560   capped   559/559
(100 %)
3 diff
(99.5 %id)
BP226117   .a 333 to 913 1 to 581       581/581
(100 %)
0 diff
(100 %id)
BG831321 epithelioid carcinoma cell line, Pancreas .a 333 to 1144 1 to 813       813/949
(85 %)
14 diff
(98.6 %id)
BP272750   .a 333 to 901 1 to 569       569/569
(100 %)
5 diff
(99.2 %id)
CB145063 Liver .a 333 to 822 1 to 490       490/490
(100 %)
3 diff
(99.4 %id)
CB145614 Liver .a 333 to 750 1 to 418       418/418
(100 %)
2 diff
(99.6 %id)
BP326236 prostata .a 333 to 916 1 to 584       584/584
(100 %)
0 diff
(100 %id)
BP349764 brain .a 333 to 912 1 to 581       581/581
(100 %)
4 diff
(99.4 %id)
BP194986 brain .a 334 to 915 1 to 582       582/582
(100 %)
0 diff
(100 %id)
DA106208 cerebellum .a 334 to 889 2 to 557   capped   556/556
(100 %)
1 diff
(99.9 %id)
DA181763 amygdala .a 334 to 785 2 to 453   capped   452/452
(100 %)
0 diff
(100 %id)
DA898172 skeletal muscle .a 334 to 821 2 to 489   capped   488/488
(100 %)
0 diff
(100 %id)
CN268995 embryonic stem cells, DMSO-treated H9 cellline .a 335 to 729 1 to 395       395/395
(100 %)
0 diff
(100 %id)
BU175613 large cell carcinoma, lung .a 336 to 1136 1 to 805       805/893
(90 %)
7 diff
(99.3 %id)
DB094600 testis .a 337 to 901 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
AA356084   .a 342 to 703 1 to 366       366/368
(99 %)
11 diff
(97.1 %id)
AF048994   .a 343 to 1430 9 to 1096 L4F AAA   1088/1096
(99 %)
7 diff
(99.4 %id)
AW965779   .a 344 to 917 1 to 574       574/574
(100 %)
10 diff
(98.3 %id)
BF038506 adenocarcinoma, ovary .a 351 to 1074 1 to 720       720/946
(76 %)
14 diff
(98.6 %id)
BE778327 eye, retinoblastoma .a 352 to 1042 1 to 691       691/714
(96 %)
5 diff
(99.3 %id)
BG768406 melanotic melanoma, high MDR (cell line), skin .a 356 to 1049 1 to 693       693/693
(100 %)
7 diff
(99.0 %id)
BG829086 muscle, rhabdomyosarcoma .a 359 to 1262 1 to 899 A193S I194H E195*     899/944
(95 %)
21 diff
(97.8 %id)
AJ224117   .a 362 to 1222 1 to 861 Q89R Q223R     861/861
(100 %)
3 diff
(99.7 %id)
BT019670   .a 362 to 1220 1 to 859       859/861
(99 %)
5 diff
(99.5 %id)
CR541820   .a 362 to 1222 1 to 861 R33K M136I     861/861
(100 %)
2 diff
(99.8 %id)
BE407918 choriocarcinoma, placenta .a 407 to 1082 1 to 672       672/792
(84 %)
15 diff
(98.2 %id)
BI223765 cervical carcinoma cell line, cervix .a 411 to 1116 1 to 707       707/707
(100 %)
4 diff
(99.5 %id)
BE746490 adenocarcinoma cell line, ovary .a 419 to 1178 6 to 763       758/779
(97 %)
16 diff
(98.0 %id)
CN268993 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 482 to 1066 1 to 585       585/585
(100 %)
1 diff
(99.9 %id)
BF690400 melanotic melanoma, high MDR (cell line), skin .a 840 to 1384 549 to 1   fully sequenced,   549/549
(100 %)
3 diff
(99.5 %id)
AL582212 B cells from Burkitt lymphoma .a 980 to 1846 870 to 6   fully sequenced,   865/870
(99 %)
0 diff
(100 %id)
AL577075 placenta, Placenta Cot 25-normalized .a 1105 to 1891 784 to 1   fully sequenced,   784/784
(100 %)
13 diff
(98.4 %id)
DB384417   .a 1363 to 1899 535 to 1       535/540
(99 %)
13 diff
(97.6 %id)
DB358281 whole embryo, mainly head .a 1381 to 1904 520 to 1   tiling clone,   520/562
(92 %)
9 diff
(98.4 %id)
DA205061 brain .b 1 to 567 2 to 568   tiling clone, capped   567/567
(100 %)
1 diff
(99.9 %id)
DA933421 Spleen .b 31 to 586 2 to 557   capped   556/556
(100 %)
2 diff
(99.7 %id)
DA017215 adrenal gland .b 69 to 513 2 to 446   capped   445/445
(100 %)
0 diff
(100 %id)
AK096913   .b 71 to 2190 1 to 2120 exact tiling clone, available from FLJ,   2120/2120
(100 %)
3 diff
(99.9 %id)
DA909342   .b 72 to 647 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
EC535993 Prostate .b 134 to 228 102 to 9       94/108
(87 %)
0 diff
(100 %id)
BF984400 duodenal adenocarcinoma, cell line, small intestine .b 474 to 1277 1 to 807 M137W D138T I139F Q140S W141G ...     807/869
(92 %)
17 diff
(98.1 %id)
TI_154093453   .b 497 to 1407 992 to 97 S12X C30A C31A S32P S33V ... AAA   896/980
(91 %)
19 diff
(98.1 %id)
BG506297 embryonal carcinoma, testis .b 519 to 1101 1 to 582       582/583
(99 %)
13 diff
(97.8 %id)
AW861893 colon .b 570 to 896 331 to 6       326/334
(97 %)
6 diff
(98.3 %id)
AW858458 colon .b 582 to 896 15 to 329       315/335
(94 %)
9 diff
(97.4 %id)
AW861918 colon .b 587 to 896 1 to 314       314/320
(98 %)
10 diff
(96.9 %id)
BM762437 myeloma .b 595 to 1026 1 to 432       432/432
(100 %)
0 diff
(100 %id)
BM839989 myeloma .b 595 to 1128 1 to 534       534/534
(100 %)
0 diff
(100 %id)
BM782115 myeloma .b 595 to 1207 1 to 613 exact     613/613
(100 %)
0 diff
(100 %id)
BM847288 myeloma .b 597 to 1114 1 to 517       517/521
(99 %)
5 diff
(99.1 %id)
AW006811 colon .b 612 to 1406 797 to 2 K2E S4E V5R E6X P7A ...     796/807
(98 %)
8 diff
(99.1 %id)
CV573717 cornea, eye .b 614 to 1216 1 to 603 E155R     603/603
(100 %)
3 diff
(99.6 %id)
CB529180 Aveolar Macrophage, lung .b 641 to 1405 783 to 19 exact AAA   765/765
(100 %)
0 diff
(100 %id)
CA435275 Fibrosarcoma .b 648 to 1407 775 to 17 S12X C30A C31A S32P S33V ... AAA   759/759
(100 %)
2 diff
(99.8 %id)
BQ896738 hepatocellular carcinoma, cell line, Liver .b 656 to 1366 1 to 714 exact     714/823
(86 %)
9 diff
(99.0 %id)
AV709318 adrenal gland .b 665 to 1016 1 to 352       352/352
(100 %)
1 diff
(99.8 %id)
CF128930 Chondrosarcoma Lung Metastasis cell lines, lung .b 665 to 1145 1 to 482       482/484
(99 %)
2 diff
(99.6 %id)
TI_154190434   .b 665 to 1401 51 to 781 K124X I151Y G152R N153H E154X     731/973
(75 %)
47 diff
(95.2 %id)
BE887509 leiomyosarcoma, uterus .b 723 to 1411 1 to 686       686/689
(99 %)
11 diff
(98.5 %id)
CA432544 cell lines, Chondrosarcoma .b 723 to 1411 707 to 19   AAA   689/689
(100 %)
6 diff
(99.2 %id)
BQ021574 lung, Metastatic Chondrosarcoma .b 736 to 1411 695 to 19   tiling clone, AAA   677/686
(98 %)
8 diff
(98.9 %id)
CA423704 cell lines, Chondrosarcoma .b 780 to 1405 644 to 19   AAA   626/626
(100 %)
3 diff
(99.6 %id)
BU620415 cell lines, Chondrosarcoma .b 780 to 1405 644 to 19   AAA   626/626
(100 %)
0 diff
(100 %id)
AA631708   .b 805 to 1180 1 to 377       377/377
(100 %)
2 diff
(99.5 %id)
BU596361 mixed (pool of 40 RNAs) .b 819 to 1410 1 to 593       593/593
(100 %)
3 diff
(99.5 %id)
AW628975 pooled .b 824 to 1409 588 to 3       586/588
(99 %)
1 diff
(99.9 %id)
AA633219 colon, colon tumor RER+ .b 830 to 1396 566 to 1       566/566
(100 %)
5 diff
(99.2 %id)
BU657200 blood .b 832 to 1419 1 to 584       588/584
(100 %)
8 diff
(98.7 %id)
BM993674 lung, Metastatic Chondrosarcoma .b 847 to 1411 583 to 19   AAA   565/565
(100 %)
0 diff
(100 %id)
AA554178 breast .b 867 to 1405 549 to 15   AAA   539/536
(100 %)
6 diff
(98.9 %id)
AI634617 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .b 881 to 1399 521 to 3       519/521
(99 %)
0 diff
(100 %id)
CB163780 Liver .b 891 to 1460 1 to 570       570/570
(100 %)
0 diff
(100 %id)
CB161784 Liver .b 891 to 1398 1 to 508       508/508
(100 %)
0 diff
(100 %id)
CV386772 lung_tumor .b 929 to 1265 27 to 361       335/363
(92 %)
11 diff
(97.0 %id)
AI928264 normal prostate, Prostate .b 932 to 1398 467 to 1       467/467
(100 %)
2 diff
(99.6 %id)
CV386832 lung_tumor .b 934 to 1265 349 to 20     Submitted on the opposite strand 330/349
(94 %)
0 diff
(100 %id)
BI115372 muscle, rhabdomyosarcoma .b 937 to 1737 1 to 824       824/957
(86 %)
25 diff
(97.4 %id)
CV379458 bladder_tumor .b 945 to 1240 1 to 296       296/296
(100 %)
0 diff
(100 %id)
BQ366993 placenta_normal .b 953 to 1373 17 to 437       421/437
(96 %)
12 diff
(97.3 %id)
BI491624.
matches multiple genes
cochlea, ear .b 963 to 1407 8 to 452   fully sequenced, AAA also hits gene koylawbo 445/452
(98 %)
6 diff
(98.7 %id)
BG000165 placenta_normal .b 986 to 1384 29 to 436       409/440
(92 %)
20 diff
(95.5 %id)
AW205579   .b 986 to 1405 437 to 18   AAA   420/430
(97 %)
0 diff
(100 %id)
BM747069 Ascites, stomach .b 986 to 1395 1 to 412       412/412
(100 %)
3 diff
(99.3 %id)
BM770862 Ascites, stomach .b 986 to 1405 1 to 420   AAA   420/420
(100 %)
0 diff
(100 %id)
TI_153989562   .b 986 to 1405 520 to 101   AAA   420/654
(64 %)
0 diff
(100 %id)
AI656465 pooled germ cell tumors .b 1019 to 1409 395 to 5       391/395
(98 %)
0 diff
(100 %id)
AW197633 pooled germ cell tumors .b 1019 to 1405 387 to 1       387/387
(100 %)
0 diff
(100 %id)
BF223130 pooled germ cell tumors .b 1020 to 1405 386 to 1       386/386
(100 %)
0 diff
(100 %id)
BI491623.
matches multiple genes
cochlea, ear .b 1034 to 1407 406 to 33   fully sequenced, AAA also hits gene koylawbo 374/374
(100 %)
7 diff
(98.2 %id)
BG111519 Bone, osteosarcoma, cell line .b 1093 to 1832 1 to 736       736/932
(78 %)
13 diff
(98.7 %id)
AA703920 bone marrow stroma .b 1111 to 1865 755 to 1       755/769
(98 %)
18 diff
(97.7 %id)
BI519726 leukocyte .b 1111 to 1807 713 to 2       712/714
(99 %)
0 diff
(100 %id)
TI_44459720   .b 1111 to 1807 713 to 2       712/714
(99 %)
0 diff
(100 %id)
BQ378121 uterus_tumor .b 1116 to 1373 258 to 1       258/259
(99 %)
5 diff
(98.1 %id)
CX752233 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .b 1169 to 1898 1 to 721     Submitted on the opposite strand 721/816
(88 %)
13 diff
(98.5 %id)
AA484226 Kidney .b 1172 to 1409 240 to 4       237/240
(98 %)
0 diff
(100 %id)
BU953478 mixed (pool of 40 RNAs) .b 1179 to 1879 1 to 703       703/752
(93 %)
15 diff
(98.1 %id)
BP240762 Liver .b 1183 to 1663 1 to 481       481/484
(99 %)
20 diff
(95.9 %id)
BP240833 Liver .b 1183 to 1757 1 to 576       576/576
(100 %)
5 diff
(99.2 %id)
BM794472 Ascites, stomach .b 1189 to 1810 1 to 622       622/622
(100 %)
0 diff
(100 %id)
CA430738 cell lines, Enchondroma .b 1200 to 1898 699 to 1   tiling clone,   699/699
(100 %)
1 diff
(99.9 %id)
FN083530 breast carcinoma .b 1235 to 1323 89 to 1     Submitted on the opposite strand 89/89
(100 %)
0 diff
(100 %id)
BG534527 lung .b 1261 to 1893 1 to 634       634/844
(75 %)
8 diff
(99.1 %id)
BQ434185 embryonal carcinoma, cell line, testis .b 1273 to 1880 1 to 608   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 608/608
(100 %)
0 diff
(100 %id)
CK902833 Pancreas, Purified pancreatic islet .b 1291 to 1885 595 to 1     Submitted on the opposite strand 595/595
(100 %)
0 diff
(100 %id)
FN060401 breast carcinoma .b 1315 to 1366 59 to 9     Submitted on the opposite strand 51/60
(85 %)
0 diff
(100 %id)
BE080861 breast .b 1325 to 1880 20 to 573   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 554/573
(96 %)
13 diff
(97.8 %id)
AI149247 uterus .b 1334 to 1880 547 to 1       547/547
(100 %)
0 diff
(100 %id)
BE645690 Prostate .b 1361 to 1880 521 to 2       520/521
(99 %)
0 diff
(100 %id)
BF038772 adenocarcinoma, ovary .b 1362 to 1880 1 to 516       516/516
(100 %)
3 diff
(99.5 %id)
BE645392 Prostate .b 1366 to 1880 515 to 1       515/515
(100 %)
2 diff
(99.7 %id)
BE877277 large cell carcinoma, undifferentiated, lung .b 1384 to 1878 1 to 495       495/495
(100 %)
2 diff
(99.6 %id)
BE867672 adenocarcinoma, colon .b 1392 to 1888 1 to 496       496/963
(51 %)
26 diff
(97.4 %id)
AA650140   .b 1401 to 1754 1 to 354       354/354
(100 %)
5 diff
(98.6 %id)
EC470028 Prostate .b 1414 to 1513 1 to 99       99/101
(98 %)
6 diff
(94.1 %id)
DA194079 amygdala .b 1438 to 2014 2 to 577   capped   576/576
(100 %)
4 diff
(99.4 %id)
AA447331 Prostate .b 1439 to 1878 17 to 455       439/464
(94 %)
4 diff
(99.2 %id)
CA774754 Pancreas, Purified pancreatic islet .b 1439 to 1860 422 to 1       422/422
(100 %)
3 diff
(99.3 %id)
AA654846   .b 1441 to 1810 1 to 368       368/368
(100 %)
2 diff
(99.5 %id)
AA418832 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 1444 to 1880 436 to 1       436/436
(100 %)
3 diff
(99.4 %id)
AI246595 pharynx, squamous cell carcinoma .b 1470 to 1880 411 to 1       411/411
(100 %)
0 diff
(100 %id)
AW974827   .b 1472 to 1923 1 to 452       452/493
(91 %)
37 diff
(92.5 %id)
AA747237 Ewing's sarcoma .b 1490 to 1892 402 to 1       402/402
(100 %)
6 diff
(98.6 %id)
AI446347 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .b 1492 to 1883 392 to 1       392/392
(100 %)
3 diff
(99.3 %id)
AA187850   .b 1519 to 1845 1 to 324       324/324
(100 %)
5 diff
(98.5 %id)
DA612116   .b 1523 to 2091 2 to 572   capped   571/571
(100 %)
3 diff
(99.5 %id)
AA635800 normal prostate, Prostate .b 1538 to 1884 344 to 1       344/344
(100 %)
7 diff
(98.0 %id)
AA659606   .b 1550 to 1814 1 to 263       263/266
(98 %)
6 diff
(97.8 %id)
AI380572 B-cell, chronic lymphotic leukemia .b 1563 to 1880 319 to 2       318/319
(99 %)
0 diff
(100 %id)
FN045991 breast carcinoma .b 1567 to 1663 1 to 97       97/98
(98 %)
1 diff
(99.0 %id)
AI370741   .b 1595 to 1880 286 to 1       286/286
(100 %)
1 diff
(99.7 %id)
BU536676 mixed (pool of 40 RNAs) .b 1622 to 1873 1 to 252   AAA Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) 252/252
(100 %)
2 diff
(99.3 %id)
AA916887 breast .b 1666 to 1880 213 to 1       213/213
(100 %)
2 diff
(99.1 %id)
AI889735 adenocarcinoma, Pancreas .b 1698 to 1875 189 to 12   AAA Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) 178/178
(100 %)
0 diff
(100 %id)
EC522432 Prostate .b 1745 to 1849 105 to 2       104/105
(99 %)
0 diff
(100 %id)
CD674323 eye, lens .c 1 to 531 1 to 532 N152K W153L F154V C155L I156Y ... tiling clone,   532/532
(100 %)
3 diff
(99.5 %id)
DA222975 brain .d 1 to 556 2 to 557 P148Q tiling clone, capped   556/556
(100 %)
1 diff
(99.9 %id)
BI044373 ovary .d 312 to 650 14 to 348   tiling clone,   335/400
(83 %)
12 diff
(97.0 %id)
DB115565 thymus .e 1 to 531 7 to 537   tiling clone, capped   536/536
(100 %)
0 diff
(100 %id)
BI828785 brain, medulla .e 24 to 750 1 to 730   tiling clone,   730/906
(80 %)
14 diff
(98.5 %id)
TI_57172597   .e 24 to 795 36 to 812   tiling clone,   777/941
(82 %)
24 diff
(97.5 %id)
BG876454 denis_drash .e 779 to 1091 324 to 13   tiling clone,   312/324
(96 %)
1 diff
(99.7 %id)
AW372894 breast .e 800 to 1098 38 to 335   tiling clone,   298/349
(85 %)
7 diff
(98.0 %id)
AL601651   .f 1 to 514 1 to 517 exact tiling clone,   517/517
(100 %)
7 diff
(98.7 %id)
AU310039.
matches multiple genes
neuroblastoma Gene RNASEH1, variant not shown         Suspected internal deletion, this clone was ignored, also hits gene nohura    
AU310039.
matches multiple genes
neuroblastoma Gene nohura, variant not shown         Suspected internal deletion, this clone was ignored, also hits gene nohura    
AU310038.
matches multiple genes
neuroblastoma Gene RNASEH1, variant not shown         Suspected internal deletion, this clone was ignored, also hits gene nohura    
AU310038.
matches multiple genes
neuroblastoma Gene nohura, variant not shown         Suspected internal deletion, this clone was ignored, also hits gene nohura    
DB294472.
matches multiple genes
  Gene RNASEH1, variant not shown       capped This clone was ignored, also hits gene nohura    
DB294472.
matches multiple genes
  Gene nohura, variant not shown       capped This clone was ignored, also hits gene nohura    
DB384588.
matches multiple genes
  Gene RNASEH1, variant not shown         This clone was ignored, also hits gene nohura    
DB384588.
matches multiple genes
  Gene nohura, variant not shown         This clone was ignored, also hits gene nohura    
DB364678.
matches multiple genes
  Gene RNASEH1, variant not shown         This clone was ignored, also hits gene rumomo    
DB364678.
matches multiple genes
  Gene rumomo, variant not shown         This clone was ignored, also hits gene rumomo    
DA732967.
matches multiple genes
  Gene RNASEH1, variant not shown       capped This clone was ignored, also hits gene rumomo    
DA732967.
matches multiple genes
  Gene rumomo, variant not shown       capped This clone was ignored, also hits gene rumomo    
H28731.
matches multiple genes
whole brain Gene RNASEH1, variant not shown       AAA This clone was ignored, also hits gene rumomo    
H28731.
matches multiple genes
whole brain Gene rumomo, variant not shown       AAA This clone was ignored, also hits gene rumomo    
H28861.
matches multiple genes
whole brain Gene RNASEH1, variant not shown         This clone was ignored, also hits gene rumomo    
H28861.
matches multiple genes
whole brain Gene rumomo, variant not shown         This clone was ignored, also hits gene rumomo    
CB054029.
matches multiple genes
brain, glioblastoma (pooled) Gene RNASEH1, variant not shown       fully sequenced, AAA This clone was ignored, also hits gene nohura    
CB054029.
matches multiple genes
brain, glioblastoma (pooled) Gene nohura, variant not shown       fully sequenced, AAA This clone was ignored, also hits gene nohura    
CB054030.
matches multiple genes
brain, glioblastoma (pooled) Gene RNASEH1, variant not shown       fully sequenced, This clone was ignored, also hits gene nohura    
CB054030.
matches multiple genes
brain, glioblastoma (pooled) Gene nohura, variant not shown       fully sequenced, This clone was ignored, also hits gene nohura    
BE293942 muscle, rhabdomyosarcoma Gene RNASEH1, variant not shown         Suspected internal deletion, this clone was ignored    
BQ433360 epithelioid carcinoma, Pancreas Gene RNASEH1, variant not shown         Submitted on the opposite strand    
CA771042.
matches multiple genes
Pancreas, Purified pancreatic islet Gene RNASEH1, variant not shown       fully sequenced, Suspected internal deletion, suspected internal deletion, this clone was ignored, also hits gene nohura    
CA771042.
matches multiple genes
Pancreas, Purified pancreatic islet Gene nohura, variant not shown       fully sequenced, Suspected internal deletion, suspected internal deletion, this clone was ignored, also hits gene nohura    
CA771342.
matches multiple genes
Pancreas, Purified pancreatic islet Gene RNASEH1, variant not shown       fully sequenced, Suspected internal deletion, suspected internal deletion, this clone was ignored, also hits gene nohura    
CA771342.
matches multiple genes
Pancreas, Purified pancreatic islet Gene nohura, variant not shown       fully sequenced, Suspected internal deletion, suspected internal deletion, this clone was ignored, also hits gene nohura    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes C